Cargando…
KIF4A as a novel prognostic biomarker in cholangiocarcinoma
Cholangiocarcinoma (CCA) is one of the most common malignant tumors. Although gene-targeted therapies have significantly improved the outcome of many cancers, the results are still not satisfactory for patients with CCA. Owing to the lack of an effective biomarker for guiding clinical treatment and...
Autores principales: | Zhang, Deng Yong, Ma, Shuo Shuo, Sun, Wan-liang, Lv, Xue Chen Huang, Lu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154480/ https://www.ncbi.nlm.nih.gov/pubmed/34032761 http://dx.doi.org/10.1097/MD.0000000000026130 |
Ejemplares similares
-
Prognostic influence for hilar cholangiocarcinoma and comparisons of prognostic values of Mayo staging and TNM staging systems
por: Sun, Zhaowei, et al.
Publicado: (2022) -
Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
por: Ji, Fengming, et al.
Publicado: (2020) -
Identification of potential prognostic long non-coding RNA for predicting survival in intrahepatic cholangiocarcinoma
por: Zhang, Zeyu, et al.
Publicado: (2020) -
Therapeutic effect of photodynamic therapy for nonresectable cholangiocarcinoma: Protocol for a meta-analysis and systematic review
por: Liu, Junjie, et al.
Publicado: (2018) -
Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer
por: Zhu, Chenhong, et al.
Publicado: (2020)